ColonAiQ is a blood-based multigene methylation test for colorectal cancer early detection. The multi-gene methylation test is a technology that analyzes the methylation level of very small amounts of circulating tumor DNA (ctDNA) in cell-free DNA (cDNA) present in blood. ColonAiQ is DNA methylation specific for early diagnosis of colorectal cancer using MONOD technique. The sensitivity and specificity of the test were increased by utilizing mGuard and MHB (Methylation haplotype block) as markers.

ColonAiQ is aimed at predicting the risk of colorectal cancer development and monitoring recurrence and minimal residual disease after surgery by precisely detecting very small amounts of cDNA in colorectal cancer patients.

As the official partner of Singlera Genomics, Epinode provides a non-invasive colorectal cancer PCR kit. Colorectal cancer is the third most common cancer worldwide. The gold standard for diagnosing colorectal cancer is colonoscopy, but colonoscopy has several inconveniences. Our product is a kit that allows for early diagnosis of colorectal cancer using blood without the inconveniences of colonoscopy (invasiveness, diet control, bleeding, etc.).